Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IBEX Ltd Director's Dealing 2025

Feb 19, 2025

32752_dirs_2025-02-18_ff745fe4-835c-4e7c-825f-847e46fe5322.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IBEX Ltd (IBEX)
CIK: 0001720420
Period of Report: 2025-02-14

Reporting Person: Casteel Julie K (Chief Sales/Marketing Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-02-14 Common Shares M 10000 $12.75 Acquired 41190 Direct
2025-02-14 Common Shares M 6574 $19 Acquired 47764 Direct
2025-02-14 Common Shares S 10000 $27.04 Disposed 37764 Direct
2025-02-14 Common Shares S 6574 $27.04 Disposed 31190 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-02-14 Stock Option (Right to Buy Common Shares) $12.75 M 10000 Disposed 2030-06-30 Common Shares (10000) Direct
2025-02-14 Stock Option (Right to Buy Common Shares) $19 M 6574 Disposed 2030-08-07 Common Shares (6574) Direct

Footnotes

F1: The shares subject to this option are fully vested and exercisable.